Inhibition of galectin-3 reduces myocardial injury and cell apoptosis in STZ-induced DCM rats by suppressing the NOX/ROS pathway. This alleviates OS damage, thereby protecting the heart from the detrimental effects of DCM. The gene discussed is LGALS3; the disease is familial dilated cardiomyopathy.